Skip to main content

Bank of New York Mellon Corp

Bank

Position in RGNX — REGENXBIO Inc.

CIK 1390777 NEW YORK, NY

Position in RGNX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,607,641
+$432,608 QoQ
Shares Held
134,194
-4.3% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in RGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. RGNX ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGNX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,607,641 134,194
2026-03-31 $1,175,033 140,219
2025-12-31 $2,096,552 145,594
2025-09-30 $1,448,782 150,133
2025-06-30 $1,183,142 144,110
2025-03-31 $1,011,007 141,400
2024-12-31 $1,245,580 161,136
2024-09-30 $3,360,879 320,389
2024-06-30 $3,972,312 339,514
2024-03-31 $6,545,773 310,668
2023-12-31 $6,063,023 337,773
2023-09-30 $5,937,052 360,696
2023-06-30 $7,335,488 366,958
2023-03-31 $6,710,835 354,883
2022-12-31 $8,141,142 358,957
2022-09-30 $8,987,678 340,056
2022-06-30 $8,283,415 335,361
2022-03-31 $11,439,628 344,671
2021-12-31 $11,240,623 343,750
2021-09-30 $14,205,555 338,873
2021-06-30 $12,432,153 320,004
2021-03-31 $11,908,926 349,133
2020-12-31 $14,276,196 314,731
2020-09-30 $8,886,647 322,916
2020-06-30 $12,830,059 348,359
2020-03-31 $11,311,562 349,338